Lyubomir T. Vezenkov
Bg
1756, Bulgaria
1756, Bulgaria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Kinetic and structural studies on the inhibition of acetylcholinesterase and butyrylcholinesterase by a series of multitarget-directed galantamine-peptide derivatives.
Journal: Chemico-biological interactions
Published: May 26, 2022
Synthesis and biological study of new galanthamine-peptide derivatives designed for prevention and treatment of Alzheimer's disease.
Journal: Amino acids
Published: December 16, 2021
Synthesis and Biological Study of 4-Aminopyridine-Peptide Derivatives Designed for the Treatment of Neurodegenerative Disorders.
Journal: Current Alzheimer research
Published: December 07, 2021
Effects of New Galantamine Derivatives in a Scopolamine Model of Dementia in Mice.
Journal: Journal of Alzheimer's disease : JAD
Published: September 27, 2021
New Galantamine Derivatives with Inhibitory Effect on Acetylcholinesterase Activity.
Journal: Journal of Alzheimer's disease : JAD
Published: August 23, 2021
Neuroprotective effect of newly synthesized 4-aminopyridine derivatives on cuprizone-induced demyelination in mice-a behavioral and immunohistochemical study.
Journal: Amino acids
Published: December 29, 2020
Effect of Original Peptide Derivatives of Galantamine on Passive Avoidance in Mice.
Journal: Bulletin of experimental biology and medicine
Published: April 30, 2020
Synthesis of New Galanthamine-Peptide Derivatives Designed for Prevention and Treatment of Alzheimer's Disease.
Journal: Current Alzheimer research
Published: July 24, 2018
Synthesis of New Peptide Derivatives of Galanthamine Designed for Prevention and Treatment of Alzheimer's Disease.
Journal: Protein and peptide letters
Published: March 26, 2015
Synthesis and in vitro study of the anticancer activity of new analogs of octreotide.
Journal: Protein and peptide letters
Published: March 02, 2012
Galantamine-based hybrid molecules with acetylcholinesterase, butyrylcholinesterase and γ-secretase inhibition activities.
Journal: Current Alzheimer research
Published: January 27, 2011
Last Updated: 09/26/2026